Kwun C. Ling
Hong Kong, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Robust cross-neutralizing antibody responses but variable cellular immunity following either Comirnaty and Spikevax JN.1-adapted mRNA vaccination in the elderly.
Journal: Vaccine
Published: December 12, 2025
A survey of respiratory physicians on investigating and managing tuberculous pleuritis.
Journal: Scientific reports
Published: December 01, 2025
Comparison of safety and immunogenicity in the elderly after receiving either Comirnaty or Spikevax monovalent XBB1.5 COVID-19 vaccine.
Journal: The Journal of infection
Published: July 17, 2024
Determination of T cell response against XBB variants in adults who received either monovalent wild-type inactivated whole virus or mRNA vaccine or bivalent WT/BA.4-5 COVID-19 mRNA vaccine as the additional booster.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: June 03, 2024
Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong: an observational cohort study.
Journal: The Lancet. Microbe
Published: May 24, 2022
A Randomized Clinical Trial Using CoronaVac or BNT162b2 Vaccine as a Third Dose in Adults Vaccinated with Two Doses of CoronaVac.
Journal: American journal of respiratory and critical care medicine
Published: January 11, 2022
Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID-19 vaccines in Hong Kong.
Journal: Respirology (Carlton, Vic.)
Published: August 21, 2021
A territory-wide study on the factors associated with recurrent asthma exacerbations requiring hospitalization in Hong Kong.
Journal: Immunity, inflammation and disease
Published: January 19, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026